Sonic Healthcare Limited (ASX:SHL)

Australia flag Australia · Delayed Price · Currency is AUD
19.98
-0.39 (-1.91%)
Apr 2, 2026, 4:10 PM AEST
Market Cap9.87B -20.5%
Revenue (ttm)10.42B +11.7%
Net Income539.40M -1.1%
EPS1.11 -2.7%
Shares Out494.08M
PE Ratio18.07
Forward PE15.62
Dividend1.07 (5.36%)
Ex-Dividend DateMar 4, 2026
Volume1,457,175
Average Volume1,765,736
Open20.31
Previous Close20.37
Day's Range19.95 - 20.63
52-Week Range19.57 - 29.24
Beta0.61
RSI33.90
Earnings DateMay 19, 2026

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, ... [Read more]

Sector Healthcare
Founded 1934
Employees 45,000
Stock Exchange Australian Securities Exchange
Ticker Symbol SHL
Full Company Profile

Financial Performance

In fiscal year 2025, Sonic Healthcare's revenue was 9.65 billion, an increase of 7.56% compared to the previous year's 8.97 billion. Earnings were 513.60 million, an increase of 0.49%.

Financial Statements